DKP Critical Insights® Syndicated Reports
DKP has developed a series of syndicated reports to provide perspectives into the oncology and rare-disease environment. The reports are designed to help you inform short- and long-term strategies that will support market positioning of your portfolio, as well as ongoing patient access to care.
Commercial Payers' Use of Compendia for Off-Label Oncology Uses
Click here for more information
- Learn how commercial payers approach clinical data through clinical compendia sources
- Identify the influence and preference of each of the CMS-recognized compendia
- Assess specific compendia level of evidence ratings accepted by a population of 83 commercial payers (96% of covered commercial lives)